| Revenue | SEK 1M | +2% |
| EBITDA | SEK 320K | +327% |
| Net profit | SEK 299K | +30% |
| Total assets | SEK 19,5M | -2% |
| Equity | SEK 5,4M | +6% |
| Employees | 0 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 565 | 846 | 971 | 984 | 1 001 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −152 | 252 | 87 | 75 | 320 |
| Depreciation & amort. | −174 | −173 | −171 | −171 | −171 |
| EBIT | −326 | 79 | −84 | −96 | 149 |
| Net financials | −156 | −143 | −214 | −273 | −271 |
| Profit before tax | −82 | −68 | 450 | 265 | 378 |
| Tax | −0 | −0 | −98 | −35 | −79 |
| Net profit | −82 | −68 | 352 | 230 | 299 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 13 120 | 13 810 | 17 293 | 19 820 | 19 516 |
| Equity | 4 593 | 4 525 | 4 876 | 5 106 | 5 405 |
| Long-term debt | 7 946 | 8 204 | 8 997 | 9 655 | 8 387 |
| Short-term debt | 581 | 1 081 | 3 265 | 4 868 | 5 427 |
| Total debt | 8 527 | 9 285 | 12 262 | 14 523 | 13 814 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EJ Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
EO Chief Auditor | Chief Auditor | 2020 – 2022 |
SJ Chief Auditor | Chief Auditor | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
| Person | Role here | Other companies |
|---|---|---|
| Erik Oskar Wall | Chief Auditor | 0 companies |
| Erik John-David Larsson | Chief Auditor | 0 companies |
| Sten Johan Pharmanson | Chief Auditor | 0 companies |
| Per-Henrik Roger Karlsson | Deputy Board Member | 0 companies |
| Mikael Ulf Robert Nicander | Board of Directors | 0 companies |
| Jan Erik Alexander Ranje | Board of Directors | 0 companies |